FDA Drug Application (202313) for ADENOSINE by EMCURE PHARMS LTD

Back to FDA Applications sponsored by EMCURE PHARMS LTD

Application Number202313
Product Number001
FormSOLUTION;IV (INFUSION)
Dosage60MG/20ML (3MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameADENOSINE
Active IngredientADENOSINE

Active IngredientCount
List of drugs with Active Ingredient ADENOSINE3


Back to FDA Applications sponsored by EMCURE PHARMS LTD